Showing posts with label Alzheimer's. Show all posts
Showing posts with label Alzheimer's. Show all posts

Tuesday, October 5, 2010

Company Announces Parkinson's Breakthrough


Rexahn Pharmaceuticals.Rexahn’s goal is to be a world-class biopharmaceutical company developing and delivering novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide. Leveraging a powerful, multi-faceted discovery engine consisting of small signaling molecule discovery, computational modeling and nanotechnology-based drug targeting and delivery, we believe that we are well on our way to achieving our goal.
CLICK HERE FOR FULL ANLAYSIS OF REXAHN PHARMACEUTICALS
Tuesday, September 21, 2010

Rexahn says study shows neuroprotective effects of clavulanic acid, main ingredient in Seradaxin drug

Clinical stage pharma company Rexahn Pharmaceuticals (NYSE Amex: RNN) said Tuesday that a published Drug Development Research article indicates that clavulanic acid, the active ingredient of the company's lead central nervous system drug Seradaxin, protects neurons from brain damage associated with neurodegnerative disease.

In the study, rodents that were exposed to different neurotoxins, were administered with clavulanic acid, which protected neurons in the hippocampus and dopaminergic regions of the brain that are critical in Alzheimer's and Parkinson's disease, respectively.

"The exciting neuronal protective properties of clavulanic acid make it a highly promising treatment for neuronal cell death diseases like Parkinson's and Alzheimer's," said Rexahn CEO Chang Ahn.

Parkinson's disease afflicts five million people worldwide, and with the aging of the baby boom generation, that population is expected to double by 2030.

According to the Alzheimer's Association, by 2050, the number of Americans aged 65 and older with Alzheimer's is projected to reach between 11 million and 16 million, unless medical breakthroughs can prevent or more effectively treat the disease.

Currently, Alzheimer's and Parkinson's therapies only provide symptomatic relief.

"Clavulanic acid has breakthrough potential of shielding the brain cell survival mechanisms, rather than fighting one-by-one the multitude of triggers that can activate the cell death mechanisms common in Alzheimer's and Parkinson's," added Ahn.

Alzheimer's has at least five major triggers, while Parkinson's has three major dysfunctioning mechanisms. Rather than intercepting and fighting each trigger, clavulanic acid has shown to broadly protect brain cell mechanisms.

Rexahn develops and commercializes therapeutics for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. The company currently has three drug candidates in Phase II clinical trials, including Archexin, Serdaxin, and Zoraxel.

The company rallied more than 3% Tuesday morning, to trade at $1.24 on NYSE Amex Exchange.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL THIS STOCK !!!!!!!!!!!!!!!

For more information contact Senior Solutions at (954) 456-8984 or toll free at 1-800-213-3524

Monday, October 4, 2010

Free Alzheimer's Guide from Johns Hopkins


Yours FREE: The Johns Hopkins
Guide to Understanding Alzheimer's Disease


It happens to us all. You're in the middle of a conversation about a book when you realize that you can't remember the title or the author's name. You start to introduce a friend to an acquaintance and suddenly can't remember either name. You find yourself standing in front of the refrigerator wondering exactly why you opened the door.

We KNOW what you're thinking:

Is it Alzheimer's disease?

Or another form of dementia?


In your FREE copy of The Johns Hopkins Guide to Understanding Alzheimer's Disease you'll discover the difference between normal memory lapses that increase with age and serious dementia.

If you're concerned about memory loss and what you can do to preserve your memory well into your senior years, you need reliable, accurate information. Where better to turn for the most cutting-edge research on memory loss than Johns Hopkins, ranked #1 of America's Best Hospitals?

Simply type in your email address below and in minutes you'll be able to download your FREE copy of The Johns Hopkins Guide to Understanding Alzheimer's Disease.

The Johns Hopkins Guide to Understanding Alzheimer's Disease is designed with YOU in mind to give you a basic overview of Alzheimer's Disease.

You will learn the difference between the memory loss commonly associated with aging, and Alzheimer's Disease.

Alzheimer's disease is certainly a worrying condition for most of us as we age, especially since our average life span is now potentially much higher than ever before. The good news is that new information about Alzheimer's and memory loss is emerging all the time.

For almost a decade, the quarterly Johns Hopkin Memory Bulletin has been bringing you the latest cutting-edge research and findings on memory loss, Alzheimer's, and other dementias.

Your free copy of The Johns Hopkins Guide to Understanding Alzheimer's Disease comes from the editors of The Johns Hopkins Memory Bulletin, so you can be sure you're getting the best, most accurate and reliable information, so you can make the most informed choices possible about your health care.

In all of the Johns Hopkins publications, our leading specialists summarize what you need to know about the results of the most important research studies and their outcomes.

Learn how to work with your doctor to preserve your memory and your overall health. Simply click on the button below for your copy of this FREE Special Report, The Johns Hopkins Guide to Understanding Alzheimer's Disease, and you'll be able to download it in moments.

Once you enter your email address, you'll receive your FREE copy of The Johns Hopkins Guide to Understanding Alzheimer's Disease PLUS your introductory email for your registration to your FREE Johns Hopkins Memory Health Alerts.

The Memory Health Alerts—delivered via email at least once a month—are packed with the latest news on Alzheimer's, dementia, and memory loss, including tips on how to preserve your memory for as long as possible.

Learn how to regain control of your life and manage your self-care better if you've been facing the challenges of memory loss for some time but have not yet sought treatment because you think nothing can be done.

There's so much new in the world of Alzheimer's and other forms of dementia that, almost every day, you hear of some new drug, promising treatment, or alternative remedy to try.

All of the Johns Hopkins publications help you sort out helpful information from hype, fact from fiction: the monthly newsletter Health After 50, the quarterly Johns Hopkins Memory Bulletin, and the annual Johns Hopkins White Paper: Memory.

Age-related memory loss can be a challenge, but educating yourself with The Johns Hopkins Guide to Understanding Alzheimer's Disease will provide you with practical advice and peace of mind. As you age, you need to stay informed about the latest breakthroughs in preventing memory loss in order to make the best choices for your treatment.

The most important thing is acting upon the best knowledge and information regarding what is safe and sensible for both short- and long-term relief of your memory loss.

The Johns Hopkins Guide to Understanding Alzheimer's Disease is authored by leading doctors and scientists at Johns Hopkins Medicine, so you know this is information you can trust, news you can use in your quest to maintain your sharp memory and cognitive function.

Few institutions have done more to research and combat Alzheimer's disease and other forms of dementia depression than the doctors and scientists at Johns Hopkins. Years of research have revealed new theories as to the causes of Alzheimer's disease, leading to the development of new medications and new treatments to help preserve cognitive function for as long as possible despite our age.

The Johns Hopkins Guide to Understanding Alzheimer's Disease is Johns Hopkins' way of reaching as many people as we can with the kind of cutting-edge information you need to make the right choices about how to preserve your memory well into your later years. Or what to do if you suspect a loved one might be suffering from memory loss, or perhaps even dementia.

Take control of your health—NOW!

Because you're reading this, it's probably safe to assume that you or someone you care about isn't feeling or acting quite the same. Perhaps they're more forgetful than usual. Millions of Americans have the same health concerns, especially since we're living longer than ever before.

You, however, stand out from the vast majority because you're actively seeking answers and making a serious effort to learn as much as you can about Alzheimer's Disease in order to try to prevent any mental decline or try to be an effective caregiver for a loved one.

That's why we are offering you a FREE copy of The Johns Hopkins Guide to Understanding Alzheimer's Disease to give you the most current advice available on strategies for avoiding memory loss and to give you the support you need to make the most informed choices possible about your health.

Please don't hesitate to take advantage of this FREE Special Report AND our FREE Johns Hopkins Memory Health Alerts.

Your free copy of The Johns Hopkins Guide to Understanding Alzheimer's Disease is available to you right now. Simply accept our FREE gift, download it, and start using it right away for better self-care.

Your introduction to your Memory Health Alerts will also arrive via email, giving you and your loved ones access to a veritable library of information and tips on preserving memory, plus the latest news on Alzheimer's disease and other dementias, and more, with a special focus on the most effective ways you can take charge of your health and retain your quality of life and mental acuity well into your senior years.

That's right, for just the few seconds it takes to enter your email address, you could gain a lifetime of benefit. You will not only have a chance to read the Special Report Johns Hopkins Guide to Understanding Alzheimer's Disease absolutely FREE, you will ALSO receive Johns Hopkins Memory Health Alerts directly in your email box AND be informed of other new Johns Hopkins Special Reports on mental health as they are published.

Why not accept this invaluable FREE offer NOW?

We're pleased that you've chosen to avail yourself of the cutting-edge information from Johns Hopkins Medicine and we wish you the best of luck in your efforts to achieve the best mental health possible.

We look forward to hearing from you now so we can send your FREE copy of Johns Hopkins Guide to Understanding Alzheimer's Disease and your FREE Johns Hopkins Memory Health Alerts! Send for your FREE Special Report and Memory Health Alerts TODAY by simply taking a moment to type your email address in the box below.

We hope you find your free copy of Johns Hopkins Guide to Understanding Alzheimer's Disease useful for you and your loved ones, and that you enjoy your registration to your free Memory Health Alerts.

For more information contact Senior Solutions at (954) 456-8984 or toll free at 1-800-213-3524

Friday, September 17, 2010

Get The Alzheimer's Caregiver Notebook


No two people experience Alzheimer’s disease in the same way. As a result, there's no one approach to caregiving. Your responsibilities can range from making financial decisions, managing changes in behavior, to helping a loved one get dressed in the morning.
Handling these duties is hard work.

But by learning caregiving skills, you can make sure that your loved one feels supported and is living a full life. You can also ensure that you are taking steps to preserve your own well-being.
Caregiver NotebookThe Alzheimer's Association Caregiver Notebook contains information and resources to help manage the challenges of caring for an individual with Alzheimer's.

Order your copy today.

In this section:
Daily Care - activities, communication, eating, bathing and more.
Behaviors - agitation, repetition, hallucinations, sundowning and other behaviors.
Safety Issues - home safety, medication safety, driving and wandering.
Coping - strategies for caregiver stress, changing relationships, grief and loss, and getting respite.
Caregiver Stress Check - take the quiz and get personalized resources.

For more information contact Senior Solutions at (954) 456-8984 or toll free at 1-800-213-3524

Tuesday, September 14, 2010

Alzheimer's Disease: 10 Warning Signs


10 warning signs of Alzheimer's:

Memory loss that disrupts daily life

One of the most common signs of Alzheimer's is memory loss, especially forgetting recently learned information. Others include forgetting important dates or events; asking for the same information over and over; relying on memory aides (e.g., reminder notes or electronic devices) or family members for things they used to handle on their own.
What's a typical age-related change? Sometimes forgetting names or appointments, but remembering them later.

Challenges in planning or solving problems

Some people may experience changes in their ability to develop and follow a plan or work with numbers. They may have trouble following a familiar recipe or keeping track of monthly bills. They may have difficulty concentrating and take much longer to do things than they did before.
What's a typical age-related change? Making occasional errors when balancing a checkbook.

Difficulty completing familiar tasks at home, at work or at leisure

People with Alzheimer's often find it hard to complete daily tasks. Sometimes, people may have trouble driving to a familiar location, managing a budget at work or remembering the rules of a favorite game.
What's a typical age-related change? Occasionally needing help to use the settings on a microwave or to record a television show.

Confusion with time or place

People with Alzheimer's can lose track of dates, seasons and the passage of time. They may have trouble understanding something if it is not happening immediately. Sometimes they may forget where they are or how they got there.
What's a typical age-related change? Getting confused about the day of the week but figuring it out later.

Trouble understanding visual images and spatial relationships

For some people, having vision problems is a sign of Alzheimer's. They may have difficulty reading, judging distance and determining color or contrast. In terms of perception, they may pass a mirror and think someone else is in the room. They may not realize they are the person in the mirror.
What's a typical age-related change? Vision changes related to cataracts.

New problems with words in speaking or writing

People with Alzheimer's may have trouble following or joining a conversation. They may stop in the middle of a conversation and have no idea how to continue or they may repeat themselves. They may struggle with vocabulary, have problems finding the right word or call things by the wrong name (e.g., calling a "watch" a "hand-clock").
What's a typical age-related change? Sometimes having trouble finding the right word.

Misplacing things and losing the ability to retrace steps

A person with Alzheimer's disease may put things in unusual places. They may lose things and be unable to go back over their steps to find them again. Sometimes, they may accuse others of stealing. This may occur more frequently over time.
What's a typical age-related change? Misplacing things from time to time, such as a pair of glasses or the remote control.

Decreased or poor judgment

People with Alzheimer's may experience changes in judgment or decision-making. For example, they may use poor judgment when dealing with money, giving large amounts to telemarketers. They may pay less attention to grooming or keeping themselves clean.
What's a typical age-related change? Making a bad decision once in a while.

Withdrawal from work or social activities

A person with Alzheimer's may start to remove themselves from hobbies, social activities, work projects or sports. They may have trouble keeping up with a favorite sports team or remembering how to complete a favorite hobby. They may also avoid being social because of the changes they have experienced.
What's a typical age-related change? Sometimes feeling weary of work, family and social obligations.

Changes in mood and personality

The mood and personalities of people with Alzheimer's can change. They can become confused, suspicious, depressed, fearful or anxious. They may be easily upset at home, at work, with friends or in places where they are out of their comfort zone.
What's a typical age-related change? Developing very specific ways of doing things and becoming irritable when a routine is disrupted.

For more information contact Senior Solutions at (954) 456-8984 or toll free at 1-800-213-3524

Sunday, August 15, 2010

Alheimer's Disease 2010 Facts & Figures


Alzheimer's Facts and Figures


This report details the escalation of Alzheimer's, which currently impacts over 5 million Americans. Facts and Figures conveys the burden of Alzheimer's and dementia on individuals, families, local and state government and the nation's healthcare system.
Highlights from the report:

African-Americans and Hispanics are at greater risk
Key facts about Alzheimer's disease
Alzheimer facts in each state

The 2010 report includes data on:

Prevalence
Mortality
Costs of Alzheimer care
Caregiving
Special report on race, ethnicity and Alzheimer's disease

View news release

African-Americans and Hispanics are at greater risk
The most significant new information coming from this year's report: African-Americans and Hispanics are at higher risk for developing Alzheimer's. African-Americans are about twice as likely to have Alzheimer's than whites, and Hispanics are about 1.5 times more likely than whites to develop the disease.

Although there appears to be no known genetic factor for these differences, the report examines the impact of health conditions like high blood pressure and diabetes, conditions that are prevalent in the African-American and Hispanic communities and how these conditions also increase Alzheimer risk.

Another interesting aspect explored is the fact that although African-Americans and Hispanics have a higher rate of Alzheimer's and dementia, they are less likely than whites to have a diagnosis. The report examines the implications of this later diagnosis on families and healthcare costs.

Key facts about Alzheimer's disease

5.3 million people have Alzheimer's
172 billion dollars in annual costs
7th leading cause of death
10.9 million unpaid caregivers

Alzheimer's disease mortality is on the rise!

With a rapidly aging baby boomer population, Alzheimer's will continue to impact more lives. From 2000-2006, Alzheimer's disease deaths increased 46.1 percent, while other selected causes of death decreased. Strategic investments in other diseases have resulted in declines in deaths, and we need to see the same type of investment for Alzheimer's. View full report.

For more information contact Senior Solutions at (954) 456-8984 or toll free at 1-800-213-3524

Wednesday, July 21, 2010

Alzheimer's Patients Respond to Books


Many Alzheimer’s Patients Find Comfort in Books
By MILT FREUDENHEIM

Familiar music can engage those with Alzheimer’s when almost nothing else can, researchers have shown. Now it appears that books written for these patients may have a similar effect.

Researchers have found in a number of studies that reading can improve a patient’s quality of life. The meanings of written sentences can be understood by — and prompt cogent responses from — even those who have difficulty handling verbal exchanges.

Caregivers may be surprised to learn that reading ability is not always destroyed by Alzheimer’s. “All of my research demonstrates that people who were literate maintain their ability to read until the end stages of dementia,” said Michelle S. Bourgeois, a professor of speech and hearing science at Ohio State University.

At the earlier stages of Alzheimer’s disease, many literate patients may still enjoy reading books themselves, said Dr. Barry Reisberg, a professor of psychiatry and director of the Fisher Alzheimer’s program at New York University. Large-type reading materials can be used to assist later-stage Alzheimer’s patients to continue reading.

Even at later stages of the disease, many patients are engaged by books read to them. Lydia Burdick, a businesswoman in New York, was able to get her mother to respond by reading to her even at a relatively late stage of Alzheimer’s disease, although it had long been hard to get through to her.

One afternoon she persuaded her mother to read a sentence — “I love to feel the sunshine on my face” — and asked, “How does the sun feel?”

“Warm,” her mother said, and both women smiled.

Ms. Burdick went on to write three books for caregivers to read aloud to, or with, “memory-challenged” adults.

Books published for children and young adults may be easy to read, but they can be off-putting for people with Alzheimer’s. “If they see something as being childish, you have lost them,” Dr. Reisberg said.

The illustrations in Ms. Burdick’s books are based on realistic watercolors of white-haired men and women and their families, created by artist Jane Freeman, a friend of Ms. Burdick. The messages are clear and upbeat. “In November, I am thankful for so many things,” she writes. “In December, I celebrate the holidays. Let’s sing a song.”

“It is not just reading anything,” Ms. Burdick said. “It has to be personally relevant to the person, and the size of the print has to be big enough for them to see it.” Suggestions for starting a conversation and appropriate songs for each page are listed at the end of two of the books.

“I used to buy children’s books with big pictures, big words, about animals for my mother, who has advanced dementia,” said Jill Eikenberry, a New York-based actress. “Now to be able to have a book with pictures and words with somebody her age sitting on a chair enjoying the sunset — it’s a really inspired idea.”

Dr. Peter V. Rabins, director of geriatric psychiatric programs at Johns Hopkins School of Medicine, said, “Anything that helps make it easier for people to interact produces benefits in both directions — the family member with the disease and the caregiver. It gives the person with the disease a chance to interact with grandkids or younger children,” he said. “It’s positive both ways.”

For more information contact Senior Solutions at (954) 456-8984 or toll free at 1-800-213-3524

Tuesday, July 13, 2010

Alzheimer's On the Rise


A new national report shows the incidence of Alzheimer's disease is growing rapidly, with a half-million new Alzheimer's diagnoses predicted for 2010.

According to the report, "2010 Alzheimer's Disease Facts and Figures," released by the Alzheimer's Association:

• There are 5.3 million Americans living with Alzheimer's disease

• Every 70 seconds someone in America develops Alzheimer’s disease

• African-Americans are about two times more likely and Hispanics are about one and one-half times more likely than their white counterparts to have Alzheimer’s and other dementias

• By mid-century someone will develop Alzheimer’s every 33 seconds

• Alzheimer’s was the seventh leading cause of death in the country in 2006, the latest year for which final death statistics are available. It was the fifth leading cause of death among individuals aged 65 and older

• From 2000-2006, death rates have declined for most major diseases—while Alzheimer’s disease deaths rose 46.1 percent.

"There are no known genetic factors that can explain the greater prevalence of Alzheimer’s and other dementias in African-Americans and Hispanics than in whites," read a statement from the association. "On the other hand, conditions, such as high blood pressure and diabetes, which are known risk factors for Alzheimer’s and other dementias in all groups, are more common in African-Americans and Hispanics than in whites."

For more information contact Senior Solutions at (954) 456-8984 or toll free at 1-800-213-3524

Sunday, June 27, 2010

Can Brain Scans Detect Alzheimer's?


CHICAGO (Reuters) - People with a family history of Alzheimer's disease often have clumps of a toxic protein in their brains even though they are perfectly healthy, researchers said on Monday.

They said the findings could lead to new ways to identify people most likely to develop Alzheimer's disease, when there is still time to do something about it.

"The hope is to one day be able to diagnose very clearly the Alzheimer's disease process before any symptoms occur, when the brain is still healthy. Then the treatments would have the best chance of success," said Lisa Mosconi of New York University Langone Medical Center, whose study appears in the Proceedings of the National Academy of Sciences.

The team wants to continue to follow the people in the study to see whether they develop dementia, and they want to replicate the findings in a much larger study.

Several teams have been working on better ways to detect early-stage Alzheimer's disease in hopes of developing drugs that can fight it before it causes too much damage.

Current treatments cannot reverse the course of Alzheimer's, a mind-robbing form of dementia that affects more than 26 million people globally.

Mosconi's team used an imaging technique called positron emission tomography or PET with a fluorescent dye called Pittsburgh Compound B that lights up clumps of a protein called beta amyloid that are a hallmark of Alzheimer's disease.

The team imaged the brains of 42 people with an average age of 65, all with healthy brain function. Of these, 14 people had mothers who had Alzheimer's; 14 had fathers with the disease; and 14 had parents with healthy brain function.

Brain scans of all 42 showed that those whose parents -- either fathers or mothers -- had Alzheimer's were more likely to have amyloid plaques in their brains.

This was especially true of people whose mothers had Alzheimer's.

"They have pretty much 20 percent more amyloid beta deposits in their brains. In other words, they had an almost four times greater risk for amyloid beta pathology," Mosconi said in a telephone interview.

The finding confirms other studies that suggest having a mother with Alzheimer's may be a greater risk factor.

"It looks like if you have maternal history of Alzheimer's disease, the risk of amyloid beta plaque and a reduction in brain activity is much greater as compared to having a father affected," Mosconi said.

After advanced age, a family history of Alzheimer's is the single biggest risk factor for developing the disease.

Not everyone who has beta amyloid plaques in their brain develops Alzheimer's disease, but Mosconi said having the plaques does increase the risk.

For more information contact Senior Solutions at (954) 456-8984 or toll free at 1-800-213-3524

Friday, June 25, 2010

Dementia Defined


To many, Alzheimer’s disease is a thief. It is the illness that steals their loved one and replaces them with someone else.

Belleville resident Sue Cooke is all too familiar with Alzheimer’s disease. One of the few words she ever hears her 79-year-old mother speak anymore is “Help.”
Since the diagnoses three years ago, her mother’s condition has declined rapidly.
“Before, you could see she would know who you were at first,” says Cooke.
“When you said ‘I’m so and so,’ you could see it in her eyes – you could see it click in, but that doesn’t happen anymore,” she says.

Alzheimer’s is a disease of the brain and the most common form of dementia.
According to Kristel Nicholas, public education co-ordinator with the local chapter of the Alzheimer Society, there are several different types of dementia. The important thing, she says, is in understanding what dementia is.

“Dementia is someone having trouble with understanding, reasoning, judgment, making decisions and short-term memory. If someone is experiencing those symptoms, those are symptoms of dementia and Alzheimer’s disease is the most common type of dementia,” says Nicholas.
To simplify the relationship between dementia and Alzheimer’s disease, Nicholas uses the analogy of an umbrella.

“Underneath the umbrella, all the little spokes that are coming down, those each represent a different type of dementia. So that’s where the Alzheimer’s disease would be – it would be one of those spokes along with some other common types of dementia, like vascular dementia, Pick’s disease, Lewy body dementia – there’s so many different kinds,” she says.
First identified in 1906, Alzheimer’s disease was discovered by Dr. Alois Alzheimer. It was then he described two distinctive characteristics of the disease - what he described as “plaques” and “tangles.”
“I’m definitely not a neurologist and I don’t pretend to be, but my understanding of it is that it’s the plaques that are attacking the brain cells. They choke them and cause them to shrink and die. And when we lose brain cells, we don’t grow new ones,” explains Nicholas.
“So part of the problem going on in the brain is that the connections are just not getting through. It’s the plaques that are doing the attacking and the damage and then the tangles are what’s left behind,” she says.
As the plaques and tangles develop, the brain shrinks and brain function decreases.
Cooke has witnessed the evidence of these symptoms in her mother. Last year, they had to have her placed in a nursing home.
“She doesn’t know how to eat anymore. They have to help her. They have to remind her what to do. Like, I can tell she’s forgetting how to eat,” says Cooke.
Cooke’s parents have been together for more than 60 years, but now her father lives alone in their marital home.
“It’s hardest on him because they’ve been together so long. And it’s sort of taken his wife away. They are each other’s lives. They always have been,” says Cooke.
“Unless he’s not feeling good, he goes every single day to see her,” she adds.
For many family members, the most upsetting aspect of the disease is the effect it has on the memory of their loved one, particularly the short-term memory.
Nicholas can also explain that in the most simplistic of terms.
“If you can picture knitting a scarf and you’ve got the two needles, and you’re casting on those first few stitches, those represent the person’s earliest memories in life – the very first things that they can remember doing. And throughout your life, you lay down all of these memories, all of these stitches in layers and so as time goes on, you end up with this long gorgeous scarf of all of your memories.
“When someone develops a dementia like Alzheimer’s disease, their knitting stops. No more new stitches are laid down. No more new memories. Instead, what begins to happen for them, is that their scarf starts to unravel from the most recent stitches that were knit, form the most recent memories that were laid down,” says Nicholas.
Determining how far the “scarf” has unravelled is essential to understanding the effect the disease is having.
“However far it’s unravelled, that is now their new reality,” says Nicholas.
“No amount of arguing or reasoning or logic is going to bring them back. We need to jump in there with them and be with them in their reality,” she says.
Sadly, for Cooke’s mother, “reality” does not include her four children.
“Dad - she sometimes knows who he is, sometimes not. She doesn’t always recognize him,” she says, adding, “she knows she likes him, but that’s about it.”
Cooke’s mother is now living somewhere in the distant past – in a time when her father played a key role.
“Sometimes she calls dad ‘Chuck’ – that’s her father,” says Cooke.
According to the Alzheimer Society of Canada, one in 11 Canadians over the age of 65 develops some form of dementia. For Canadians over the age of 85, the occurrence is even higher: one in three.
Age, says Nicholas, is a definite risk factor.
“We know that as people age, their likelihood of developing this disease increases,” she says.
But, she says, “more and more, this disease seems to be affecting younger people.”
Prior to the age of 65, the disease is categorized as early onset Alzheimer’s.
“Just since January, we’ve had probably half a dozen people come to us between the age of 50 and 65,” says Nicholas.
“I have a couple of gentlemen in their 50s,” she says.
Regardless of the individual’s age, understanding their memories, and the emotional connection to them, is the key.
“That will help you as they go backwards in their memories to know what’s going on, and memories and emotions are so closely linked, “ says Nicholas.
“Communicating with words becomes harder and harder for people with any kind of dementia and so if you don’t have your words, it’s the non-verbal behaviour that they rely on - that we rely on them for. So we need to be really good at reading their non-verbal behavior and their cues because eventually they’re not going to be able to tell us with words what the problem is,” says Nicholas.
For Cooke, the word “help” could mean so much. She isn’t really sure what her mother is trying to communicate in that one, simple word and it is getting increasingly difficult to “help” her mother.
“Her health is pretty good, but it’s her mind,” she says. “But as your mind goes, your health goes too,” she says.




For more information contact Senior Solutions at (954) 456-8984 or toll free at 1-800-213-3524

Sunday, June 20, 2010

Slowing the Onset of Alzheimer's Disease


FROM THE NIH
Targeting the Blood-Brain Barrier May Delay Progression of Alzheimer's Disease:

Researchers may be one step closer to slowing the onset and progression of Alzheimer's disease. An animal study supported by the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, shows that by targeting the blood-brain barrier, researchers are able to slow the accumulation of a protein associated with the progression of the illness. The blood-brain barrier separates the brain from circulating blood, and it protects the brain by removing toxic metabolites and proteins formed in the brain and preventing entry of toxic chemicals from the blood.

"This study may provide the experimental basis for new strategies that can be used to treat Alzheimer’s patients," said David S. Miller, Ph.D., chief of the Laboratory of Toxicology and Pharmacology at NIEHS and an author on the paper that appears in the May issue of Molecular Pharmacology.

Alzheimer's is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, and eventually disrupts function of major organs. Estimates vary, but experts suggest that as many as 2.6 million to 5.1 million Americans may have Alzheimer’s. One hallmark of Alzheimer's is the deposition of beta-amyloid protein in the brain. This protein clumps to form plaques that destroy neurons and lead to cognitive impairment and memory loss in Alzheimer patients.

"What we've shown in our mouse models is that we can reduce the accumulation of beta-amyloid protein in the brain by targeting a certain receptor in the brain known as the pregnane X receptor, or PXR," said Miller.

The researchers from NIEHS and the University of Minnesota Duluth demonstrated that when 12-week-old genetically modified mice expressing human beta-amyloid protein are treated with a steroid-like chemical that activates PXR, the amount of beta-amyloid protein in the brain is reduced. The activation of the PXR was found to increase the expression of a blood-brain barrier protein known as P-glycoprotein. This protein transports beta-amyloid out of the brain.

"Our results show several new findings. We now know that P-glycoprotein plays a pivotal role in clearing beta-amyloid from the brain. Secondly, we know P-glycoprotein levels are reduced in the blood-brain barrier, and that the Alzheimer's mice treated with the chemical to activate PXR were able to reduce their beta-amyloid levels to that of mice without Alzheimer's," said Bjorn Bauer, Ph.D., assistant professor at the University of Minnesota and senior author on the paper.

Anika Hartz, Ph.D., lead author on the study, added that it is also likely that reduced P-glycoprotein expression at the blood-brain barrier may be an early indicator of Alzheimer’s disease, even before the cognitive symptoms appear. One of the challenges confronting the diagnosis and treatment of Alzheimer's is being able to clearly diagnose the disease process when brain damage is minimal, before any symptoms occur.

"More research is needed before this animal model discovery can be tested in humans, but the paper suggests some new targets for treatment that offer hope to patients and families dealing with this devastating disease," said NIEHS Director Linda Birnbaum, Ph.D.

The researchers plan to conduct a study where the Alzheimer's mice are fed a PXR-activating compound in their diet for 12-18 months. The cognitive skills of the animals will be monitored regularly, along with their P-glycoprotein levels, to determine whether the feeding regimen delays the onset of cognitive impairment.


For more information contact Senior Solutions at (954) 456-8984 or toll free at 1-800-213-3524